openPR Logo
Press release

Glioma Treatment Market Driven By The Surge In Demand For Personalized Medicine: A Significant Driver Propelling The Glioma Treatment Market In 2025

04-29-2025 07:13 AM CET | Health & Medicine

Press release from: The Business Research Company

Glioma Treatment

Glioma Treatment

The Glioma Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Glioma Treatment Market Size and Projected Growth Rate?
The Glioma Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Glioma Treatment Market Size and Projected Growth Rate?

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10689

What Are the Major Segments in the Glioma Treatment Market?
The glioma treatment market covered in this report is segmented -

1) By Type: Low-Grade, High-Grade
2) By Disease: Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Other Diseases
3) By Route Of Administration: Oral, Parenteral, Other Routes
4) By Treatment: Surgery, Radiation Therapy, Chemotherapy, Targeted Drug Therapy, Other Treatments
5) By End-User: Hospitals, Specialty Clinics, Other End Users

Subsegments:
1) By Low-Grade: Astrocytoma, Oligodendroglioma, Mixed Glioma
2) By High-Grade: Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10689&type=smp

What Are The Driving Glioma Treatment Market Evolution?
The escalating need for personalized medicine is set to boost the expansion of the glioma treatment market in the future. Personalized medicine refers to a tailored healthcare approach that incorporates unique patient attributes such as genetic factors, environment, and lifestyle, to improve treatment efficiency and outcomes. The surging demand for this type of medicine is predicated upon several aspects, including genomics advancements, patient empowerment, and enhanced treatment efficacy. The discovery of biomarkers associated with gliomas assists in predicting treatment responses and outcomes, facilitating the creation of personalized treatment strategies adapted to each patient's unique traits. For example, in February 2024, records from the US-based non-profit organization, Personalized Medicine Coalition, showed that the FDA approved 16 new personalized therapies for patients suffering from rare diseases in 2023, a significant increase from just six in 2022. Therefore, this rising demand for personalized medicine is fueling the expansion of the glioma treatment market.

Which Firms Dominate The Glioma Treatment Market Segments?
Major companies operating in the glioma treatment market include Merck & Co Inc., Amgen Inc., F Hoffmann-La Roche AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Arbor Pharmaceuticals LLC, Amneal Pharmaceuticals Inc., Karyopharm Therapeutics Inc., Bristol-Myers Squibb Co., Rigel Pharmaceuticals Inc., Sumitomo Dainippon Pharma Oncology Inc., Emcure Pharmaceuticals Ltd., Novartis AG, AstraZeneca plc, Eli Lilly and Company, Sanofi S.A., Johnson & Johnson, AbbVie Inc., Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Bayer AG, Gilead Sciences Inc., Ipsen Pharma, Eisai Co. Ltd., Genentech Inc., Iovance Biotherapeutics Inc., Agios Pharmaceuticals Inc.

What Trends Are Expected to Dominate the Glioma Treatment Market in the Next 5 Years?
The trend of product innovation is increasingly gaining traction in the glioma treatment industry. To maintain their competitive edge, major firms in the market are focusing on adopting novel, innovative products. For example, Servier Pharmaceuticals, a pharmaceutical corporation based in France, received approval from the FDA in June 2024 for VORANIGO (vorasidenib) tablets. This marked a substantial achievement as the initial targeted therapy for Grade 2 IDH-mutant glioma. Vorasidenib acts as a dual inhibitor that targets isocitrate dehydrogenase (IDH) mutations 1 and 2, commonly found in gliomas. These mutations result in the production of 2-hydroxyglutarate (2-HG), a growth and survival facilitating metabolite for tumors. The inhibition of these enzymes by vorasidenib, thereby reducing 2-HG levels, could potentially slow down tumor progression.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/glioma-treatment-global-market-report

Which Is The Largest Region In The Glioma Treatment Market?
North America was the largest region in the glioma treatment market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global glioma treatment market report during the forecast period. The regions covered in the glioma treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Glioma Treatment Market?
2. What is the CAGR expected in the Glioma Treatment Market?
3. What Are the Key Innovations Transforming the Glioma Treatment Industry?
4. Which Region Is Leading the Glioma Treatment Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Glioma Treatment Market Driven By The Surge In Demand For Personalized Medicine: A Significant Driver Propelling The Glioma Treatment Market In 2025 here

News-ID: 3991739 • Views:

More Releases from The Business Research Company

Emerging Trends to Reshape the Vertical Farming Market: Technological Advancements And Sustainable Practices In Vertical Farming as a Key Influencer
Emerging Trends to Reshape the Vertical Farming Market: Technological Advancemen …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Vertical Farming Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The size of the vertical farming market has seen rapid growth in recent years. Predictions estimate it will increase from $7.74 billion in 2024 to $9.55 billion in 2025. This represents a compound annual growth
Plant Breeding And CRISPR Plants Market Landscape to 2034: Key Forces Shaping the Next Decade of Growth
Plant Breeding And CRISPR Plants Market Landscape to 2034: Key Forces Shaping th …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Plant Breeding And CRISPR Plants Market Size By 2025? In recent years, the market size for plant breeding and CRISPR plants has seen considerable growth. It stands projected to escalate from $13.56 billion in 2024 to a noteworthy $15.5 billion in 2025, boasting a compound
Soaring Demand Set to Propel Livestock Monitoring Market to $7.14 Billion by 2029
Soaring Demand Set to Propel Livestock Monitoring Market to $7.14 Billion by 202 …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Livestock Monitoring Market Through 2025? In recent times, there has been a significant increase in the livestock monitoring market size. The market, which stands at $3.48 billion in 2024, is projected to rise to $3.94 billion by 2025, depicting a compound annual
Emerging Trends to Drive Forestry And Logging Market Growth at 7.9% CAGR Through 2029
Emerging Trends to Drive Forestry And Logging Market Growth at 7.9% CAGR Through …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Forestry And Logging Market Size Growth Forecast: What to Expect by 2025? The market size for forestry and logging has seen a substantial growth in the past couple of years. It is expected to increase from $980.05 billion in 2024 to $1055.36 billion in 2025, with a compound annual

All 5 Releases


More Releases for Treatment

Trigeminal Neuralgia Treatment Market Size, Trigeminal Neuralgia Treatment Marke …
Trigeminal Neuralgia Treatment Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Trigeminal Neuralgia Treatment research data, benefit, gross margin, worldwide market
Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value. View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products. Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products. Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview: The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025. Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any